These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 24429801)

  • 1. Increased expression of macrophage migration inhibitory factor in aorta of patients with coronary atherosclerosis.
    Gong Z; Xing S; Zheng F; Xing Q
    J Cardiovasc Surg (Torino); 2015 Aug; 56(4):631-7. PubMed ID: 24429801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRP3 inflammasomes show high expression in aorta of patients with atherosclerosis.
    Zheng F; Xing S; Gong Z; Xing Q
    Heart Lung Circ; 2013 Sep; 22(9):746-50. PubMed ID: 23462287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of caspase-1 in aorta of patients with coronary atherosclerosis.
    Zheng F; Gong Z; Xing S; Xing Q
    Heart Lung Circ; 2014 Nov; 23(11):1070-4. PubMed ID: 24954757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of activated nuclear factor-kappa B in aorta of patients with coronary atherosclerosis.
    Zhang W; Xing SS; Sun XL; Xing QC
    Clin Cardiol; 2009 Dec; 32(12):E42-7. PubMed ID: 20014193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum macrophage migration inhibitory factor levels are associated with angiographically complex coronary lesions in patients with coronary artery disease.
    Hao Y; Yi SL; Zhong JQ
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):556-60. PubMed ID: 26263432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.
    Müller II; Müller KA; Karathanos A; Schönleber H; Rath D; Vogel S; Chatterjee M; Schmid M; Haas M; Seizer P; Langer H; Schaeffeler E; Schwab M; Gawaz M; Geisler T
    Atherosclerosis; 2014 Dec; 237(2):426-32. PubMed ID: 25463068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT5-8): Relationship with soluble MIF levels in coronary atherosclerotic disease subjects.
    Qian L; Wang XY; Thapa S; Tao LY; Wu SZ; Luo GJ; Wang LP; Wang JN; Wang J; Li J; Tang JF; Ji KT
    BMC Cardiovasc Disord; 2017 Jun; 17(1):144. PubMed ID: 28578664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation.
    Akboga MK; Canpolat U; Sahinarslan A; Alsancak Y; Nurkoc S; Aras D; Aydogdu S; Abaci A
    Atherosclerosis; 2015 May; 240(1):110-4. PubMed ID: 25770689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor expression and MIF gene -173 G/C polymorphism in nonalcoholic fatty liver disease.
    Akyildiz M; Gunsar F; Nart D; Sahin O; Yilmaz F; Akay S; Ersoz G; Karasu Z; Ilter T; Batur Y; Berdeli A; Akarca U
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):192-8. PubMed ID: 19829123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor is associated with aneurysmal expansion.
    Pan JH; Lindholt JS; Sukhova GK; Baugh JA; Henneberg EW; Bucala R; Donnelly SC; Libby P; Metz C; Shi GP
    J Vasc Surg; 2003 Mar; 37(3):628-35. PubMed ID: 12618703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in lipoprotein (a) and apolipoprotein (a) levels in men and women with advanced coronary atherosclerosis.
    Stiel GM; Reblin T; Bührlen M; Lattermann A; Nienaber CA
    Coron Artery Dis; 1995 Apr; 6(4):347-50. PubMed ID: 7655720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Plasma Levels of Gremlin-1 and Macrophage Migration Inhibitory Factor, but Not Their Ratio, Indicate an Increased Risk for Acute Coronary Syndrome in Patients With Type 2 Diabetes Mellitus.
    Müller KA; Rath D; Schmid M; Schoenleber H; Gawaz M; Geisler T; Müller II
    Clin Cardiol; 2016 Apr; 39(4):201-6. PubMed ID: 27101443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage migration inhibitory factor is associated with vascular dysfunction in patients with end-stage renal disease.
    Rammos C; Hendgen-Cotta UB; Sobierajski J; Adamczyk S; Hetzel GR; Kleophas W; Dellanna F; Kelm M; Rassaf T
    Int J Cardiol; 2013 Oct; 168(6):5249-56. PubMed ID: 23978362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High plasma levels of macrophage migration inhibitory factor are associated with adverse long-term outcome in patients with stable coronary artery disease and impaired glucose tolerance or type 2 diabetes mellitus.
    Makino A; Nakamura T; Hirano M; Kitta Y; Sano K; Kobayashi T; Fujioka D; Saito Y; Watanabe K; Watanabe Y; Kawabata K; Obata JE; Kugiyama K
    Atherosclerosis; 2010 Dec; 213(2):573-8. PubMed ID: 20934703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Macrophage migration inhibitory factor (MIF) gene -173 G>C polymorphism and its relationship to coronary artery disease and type 2 diabetes].
    Çoban N; Erkan AF; Ekici B; Kaşit M; Erginel Ünaltuna N; Vurgun E
    Turk Kardiyol Dern Ars; 2019 Jan; 47(1):29-37. PubMed ID: 30628898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between toll-like receptor 4 levels in aorta and severity of atherosclerosis.
    Xing S; Zheng F; Zhang W; Wang D; Xing Q
    J Int Med Res; 2014 Aug; 42(4):958-65. PubMed ID: 24925583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Migration Inhibitory Factor Induces Inflammation and Predicts Spinal Progression in Ankylosing Spondylitis.
    Ranganathan V; Ciccia F; Zeng F; Sari I; Guggino G; Muralitharan J; Gracey E; Haroon N
    Arthritis Rheumatol; 2017 Sep; 69(9):1796-1806. PubMed ID: 28597514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of laboratory parameters as risk factors for the presence and the extent of coronary or carotid atherosclerosis: the significance of apolipoprotein B to apolipoprotein all ratio.
    Cerne D; Ledinski G; Kager G; Greilberger J; Wang X; Jürgens G
    Clin Chem Lab Med; 2000 Jun; 38(6):529-38. PubMed ID: 10987202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.